Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. 2006

Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
Departmennt of Internal Medicine, Justus-Liebig-University Giessen, Klinikstrasse 36, 35392 Giessen, Germany.

Treatment of hemodynamic instability in septic shock often demands the administration of vasopressor agents, although these may have deleterious effects on microcirculatory homeostasis. Inhibition of nitric oxide synthase (NOS) has been suggested as an alternative therapeutic approach, as NO formation may be excessively increased in sepsis. To compare the effects of epinephrine titration, non-selective NOS inhibition by L-NMMA and selective inhibition of inducible NOS (iNOS) by 1400W on hemodynamics and on the regulation of microcirculation in a rat model of endotoxic shock, we intravenously injected endotoxin (LPS) or saline to male Wistar rats and after 2 hours randomized LPS treated rats into four different groups that received either saline, norepinephrine, L-NMMA or 1400W (n = 6 per group). Three hours after LPS administration, rats presented with severe systemic arterial hypotension (64 +/- 3 vs. 115 +/- 4 mmHg, p < 0.001), unresponsiveness to volume treatment, lactate acidosis and a marked increase in plasmatic nitrite and nitrate levels (15 +/- 8 vs. 263 +/- 47 microM, p < 0.001). Measurement of the tissue oxygenation in the ileum mucosal layer by the Erlangen micro-lightguide spectrophotometer (EMPHO) technique demonstrated marked heterogeneity of hemoglobin saturation, with appearance of low oxygenated areas. Norepinephrine, usually stabilizing blood pressure (99 +/- 7 vs. 67 +/- 4 mmHg 60 min after infusion, p < 0.01), increased lactate formation (7.9 +/- 0.2 vs. 3.7 +/- 0.5 mM, p < 0.001) and drastically increased low oxygenated regions in the ileum mucosal layer. L-NMMA similarly increased blood pressure (92 +/- 6 vs. 67 +/- 4 mmHg 60 min after infusion, p < 0.05), but did not enhance lactate acidosis. However, some further deterioration of mucosa oxygenation was again noted. 1400W forwarded stabilization of blood pressure (88 +/- 5 vs. 67 +/- 4 mmHg 60 min after injection, p < 0.05), reduced plasmatic nitrite and nitrate levels similar to L-NMMA, without an aggravation of lactate acidosis. In addition, mucosal oxygenation did not deteriorate in response to this agent. Thereby, we conclude that in a rat model of endotoxic shock selective iNOS inhibitors are superior to non-specific NOS inhibitors and in particular to norepinephrine for the treatment of macro- and microcirculatory abnormalities in experimental septic shock.

UI MeSH Term Description Entries
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D000578 Amidines Derivatives of oxoacids RnE(
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene

Related Publications

Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
February 2005, Sheng li xue bao : [Acta physiologica Sinica],
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
August 1999, Biochemical pharmacology,
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
August 1995, The Journal of trauma,
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
January 2009, Critical care (London, England),
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
January 1995, Shock (Augusta, Ga.),
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
January 1998, The Journal of infectious diseases,
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
August 2002, Clinical science (London, England : 1979),
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
March 2005, The Journal of pharmacology and experimental therapeutics,
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
September 1998, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Soni Savai Pullamsetti, and Daniel Maring, and Hossein Ardeschir Ghofrani, and Konstantin Mayer, and Norbert Weissmann, and Bernhard Rosengarten, and Martin Lehner, and Christian Schudt, and Rainer Boer, and Friedrich Grimminger, and Werner Seeger, and Ralph Theo Schermuly
August 1994, Clinical science (London, England : 1979),
Copied contents to your clipboard!